Examining minimal perceptible clinical improvement criteria in patients treated with hylan G-F 20 for knee ostecarthritis

被引：0
|
作者：
Bellamy, N
Bell, MJ
Goldsmith, CH
Torrance, GW
Raynauld, J
Tugwell, P
Polisson, R
Pericak, D
Walker, V
机构：
[1] Univ Queensland, Royal Brisbane Hosp, CONROD, St Lucia, Qld 4067, Australia
[2] Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada
[3] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada
[4] Univ Montreal, Montreal Inst Rheumatol, Montreal, PQ H3C 3J7, Canada
[5] Univ Ottawa, Inst Populat Hlth, Ctr Global Hlth, Ottawa, ON K1N 6N5, Canada
[6] Genzyme Corp, Clin Res Biosurg, Cambridge, MA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：357 / 357
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee osteoarthritis - A systematic review
    Espallargues, M
    Pons, JMV
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2003, 19 (01) : 41 - 56
  • [42] A randomized controlled trial evaluating effectiveness and cost-effectiveness of hylan G-F 20 in patients with knee OA
    Goldsmith, CH
    Raynauld, JP
    Torrance, GW
    Band, PA
    Bellamy, N
    Tugwell, P
    Walker, V
    Schultz, M
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 9 - 9
  • [43] Intra-articular hylan G-F 20 (Synvisc®) in the management of patellofemoral osteoarthritis of the knee (POAK)
    Clarke, S
    Lock, V
    Duddy, J
    Sharif, M
    Newman, JH
    Kirwan, JR
    KNEE, 2005, 12 (01) : 57 - 62
  • [44] Treatment of osteoarthritis knee pain: update on use of intra-articular hylan G-F 20
    Migliore, Alberto
    Giovannangeli, Francesca
    Bizzi, Emanuele
    Lagana, Bruno
    Granata, Mauro
    ORTHOPEDIC RESEARCH AND REVIEWS, 2010, 2 : 107 - 118
  • [45] Treatment of intraarticular osteoarthritis of the knee with hylan G-F 20: comment on the article by Brandt et al
    Parenti, D
    Murray, CW
    ARTHRITIS AND RHEUMATISM, 2001, 44 (06): : 1470 - 1471
  • [46] CLINICAL AND ECONOMIC IMPACT ANALYSIS OF VISCOSUPPLEMENTATION WITH HYLAN G-F 20 VERSUS HYALURONIC ACID FOR THE TREATMENT OF KNEE OSTEOARTHROSIS IN COLOMBIA
    Vasquez, E.
    Lasalvia, P.
    Upegui, A.
    Garcia, W.
    Silva, L.
    Londono, S.
    VALUE IN HEALTH, 2023, 26 (12) : S117 - S117
  • [47] A prospective randomised controlled clinical trial comparing the efficacy of Hylan G-F 20 and sodium hyaluronate in the treatment of osteoarthritis of the knee
    Raman, R.
    Dutta, A.
    Day, N.
    Shaw, C. J.
    Johnson, G. V.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 403 - 403
  • [48] A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee
    Caborn, D
    Rush, J
    Lanzer, W
    Parenti, D
    Murray, C
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (02) : 333 - 343
  • [49] Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis
    Migliore, Alberto
    Integlia, Davide
    Pompilio, Giuseppe
    Di Giuseppe, Francesca
    Aru, Cinzia
    Brown, Tray
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 : 453 - 464
  • [50] Clinical and economic impact analysis of viscosupplementation with hylan G-F 20 versus hyaluronic acids and no viscosupplementation for the treatment of knee osteoarthritis in Colombia
    Vasquez Melo, Eliana C.
    Lasalvia, Pieralessandro
    Gomez Espitia, Lina Maria
    Osorio Arango, Luz Karime
    Londono, Sergio
    Upegui, Angie
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2025, 25 (04) : 527 - 534
12345